Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics
William Blair initiates coverage on Tandem Diabetes Care and Beta Bionics, highlighting their growth potential in the insulin pump market.read more...
Benzinga
Beta Bionics, Inc. (BBNX) Reports Q2 Loss, Tops Revenue Estimates
Beta Bionics, Inc. (BBNX) delivered earnings and revenue surprises of +14.52% and +2.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders PR Newswire SAN DIEGO, July 1, 2026 SAN DIEGO, July 1, 2026 /PRNewswire/ --Johnson Fistel, PLLP is investigating potential...
PR Newswire
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders PR Newswire SAN DIEGO, June 22, 2026 SAN DIEGO, June 22, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential...
PR Newswire
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or certain of its executive officers made false or misleading statements, or failed to disclose material...
Business Wire
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth PR Newswire SAN DIEGO, June 5, 2026 SAN...
PR Newswire
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel
Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors losses and whether they may be recovered under federal securities laws.What if I purchased Beta Bionics...
Business Wire
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc...
PR Newswire
Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
Shareholder Rights law firm Robbins LLP is investigating Beta Bionics, Inc. (NASDAQ: BBNX) to determine whether certain Beta Bionics officers and directors violated securities laws and breached fiduciary duties to shareholders. Beta Bionics is a commercial-stage medical device company, engages in...
Business Wire
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by Analysts
Shares of Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold re...
MarketBeat